Provided by Tiger Trade Technology Pte. Ltd.

ANI Pharmaceuticals

74.81
+0.77001.04%
Post-market: 75.000.1900+0.25%17:26 EDT
Volume:241.53K
Turnover:17.95M
Market Cap:1.68B
PE:22.50
High:74.98
Open:73.83
Low:72.64
Close:74.04
52wk High:99.50
52wk Low:56.71
Shares:22.47M
Float Shares:20.38M
Volume Ratio:0.52
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.32
EPS(LYR):3.32
ROE:16.16%
ROA:3.82%
PB:3.11
PE(LYR):22.53

Loading ...

Director Patrick D. Walsh Reports Disposal of ANI Pharmaceuticals Inc. Common Shares

Reuters
·
Nov 18, 2025

A Fresh Look at ANI Pharmaceuticals (ANIP) Valuation After Recent Share Price Decline

Simply Wall St.
·
Nov 17, 2025

ANI Pharmaceuticals SVP Chad Gassert Reports Sale of Common Shares

Reuters
·
Nov 15, 2025

Meredith Cook, Sr. VP and General Counsel, Reports Sale of ANI Pharmaceuticals Inc. Common Shares

Reuters
·
Nov 15, 2025

ANI Pharmaceuticals Is Maintained at Buy by Guggenheim

Dow Jones
·
Nov 10, 2025

ANI Pharmaceuticals Highlights November 2025 Financial Strategies

TIPRANKS
·
Nov 10, 2025

ANI Pharmaceuticals Inc. Highlights Strong Revenue and EBITDA Growth in Latest Corporate Presentation

Reuters
·
Nov 10, 2025

ANI Pharmaceuticals: Strong Commercial Execution and Promising Growth Prospects Reinforce Buy Rating

TIPRANKS
·
Nov 08, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Novo Nordisk, Block, Peloton Interactive

Reuters
·
Nov 08, 2025

Stock Track | ANI Pharmaceuticals Soars 5.29% on Strong Q3 Results and Raised 2025 Outlook

Stock Track
·
Nov 07, 2025

Stock Track | ANI Pharmaceuticals Plummets 7.78% Despite Strong Q3 Results and Raised Guidance

Stock Track
·
Nov 07, 2025

BUZZ-U.S. STOCKS ON THE MOVE-ANI Pharmaceuticals, Wendy's, nLIGHT

Reuters
·
Nov 07, 2025

GUIDANCE: (ANIP) ANI Pharmaceuticals Expects 2025 Adjusted EPS Range $7.37 to $7.64, vs. FactSet Est of $7.32

MT Newswires Live
·
Nov 07, 2025

ANI Pharmaceuticals beats Q3 revenue estimates on Cortrophin demand

Reuters
·
Nov 07, 2025

ANI Pharmaceuticals reports Q3 adjusted EPS $2.04, consensus $1.77

TIPRANKS
·
Nov 07, 2025

BRIEF-ANI Pharmaceuticals Q3 Adjusted EPS USD 2.04 Vs. IBES Estimate USD 1.75

Reuters
·
Nov 07, 2025

ANI Pharmaceuticals Q3 Adjusted Ebitda USD 59.6 Million

THOMSON REUTERS
·
Nov 07, 2025

ANI Pharmaceuticals Inc FY2025 Shr View $7.28, REV View $844.7 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
Nov 07, 2025

ANI Pharmaceuticals Reports Record Third Quarter 2025 Financial Results and Raises 2025 Guidance

THOMSON REUTERS
·
Nov 07, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 07, 2025